The Tagrisso train rolls on for AstraZeneca. The British pharma giant’s oncology unit recently launched its first direct-to-consumer US commercial supporting Tagrisso (osimertinib) to help lung cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results